Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Dividends

Matthews International Shares Face Dividend-Related Pressure

Dieter Jaworski by Dieter Jaworski
November 29, 2025
in Dividends
0
Matthews Stock
0
SHARES
34
VIEWS
Share on FacebookShare on Twitter

Investors in Matthews International Corporation witnessed notable share price weakness as the company approached its ex-dividend date. The equity declined 1.1% during Friday’s session, settling at $24.92 per share. Market observers attribute this downward movement to the impending dividend distribution.

Key Dividend Dates and Expected Impact

The machinery and equipment manufacturer will trade ex-dividend on December 1, 2025. This cutoff date means purchasers acquiring shares on or after this day will not receive the upcoming quarterly payment. The company has scheduled its dividend distribution for December 15, 2025.

Critical dividend details:
* Ex-dividend date: December 1, 2025
* Quarterly dividend per share: $0.255
* Payment date: December 15, 2025
* Expected share price adjustment: approximately 1.02%

Should investors sell immediately? Or is it worth buying Matthews?

The declared dividend represents exactly 1.02% of the current share value. Financial markets typically price this adjustment into equities on the ex-dividend date, suggesting Matthews International shares could open about 1.02% lower on December 1, assuming stable market conditions.

Market Position and Recent Performance

With a present market capitalization of $767.43 million, Matthews International maintains its standing within the small-cap segment. While the company has recorded a 2.96% gain year-to-date, recent dividend-related pressure and trading losses indicate the stock faces near-term headwinds.

Market participants now await December’s trading activity to determine whether the equity can rebound following the dividend-related adjustment. The company’s performance during this period will provide clearer signals about its short-term trajectory.

Ad

Matthews Stock: Buy or Sell?! New Matthews Analysis from February 7 delivers the answer:

The latest Matthews figures speak for themselves: Urgent action needed for Matthews investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Matthews: Buy or sell? Read more here...

Tags: Matthews
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Preferred Bank of Los Angeles Stock
Analysis

Preferred Bank of Los Angeles: A Case Study in Resilient Profitability

February 6, 2026
Next Post
FTC Solar Stock

FTC Solar Shares: Sustainable Recovery or Temporary Rally?

Baozun Stock

Baozun's Profitability Challenge: A Tale of Two Business Segments

Akari Therapeutics Stock

Akari Therapeutics Faces Nasdaq Compliance Challenge Amid Volatile Trading

Recommended

Abbott Laboratories Stock

Can Abbott’s AI Innovation and Dividend Track Record Propel Its Shares?

3 weeks ago

Empowering the Next Generation enCore Energys Education Society and Scholarship Programs

2 years ago
Synopsys Stock

Synopsys Shares Face Critical Test Amid Legal and Analyst Concerns

2 months ago
Technology Blockchain Trading online

Applied Digital Corporation Announces Disappointing Financial Performance and Decline in Stock Price

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

Yirendai Charts a New Course with Tech-Driven Strategy

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Trending

Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

by Rodolfo Hanigan
February 7, 2026
0

Shares of HBT Financial have recently climbed to a new 52-week peak of $29.37, propelled by a...

Allscripts Healthcare Stock

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Avanos Medical Stock

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • HBT Financial Stock Surges as Strategic Acquisition Nears Completion
  • Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth
  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com